Loading
ReadUpdated Aug 18, 2026
Analysis
Trade-policy analysis for import-scope decisions, written from the public record. Start from a product line, origin, supplier, or case, then read what the record changes for that file.
Published pieces210 in the archive
Current leadPolicy monitoring
SourcingCitable public records
Written forImport and customs teams
Browse
Topics
Trade policy40 piecesPolicy monitoringTrade remedies10 piecesAD/CVD ordersInjury determination+1Customs enforcement20 piecesClassification and valuationUFLPA enforcement+2Tariff authority58 piecesSection 301 trackSection 122 surcharge+2Entry posture review29 piecesRefund postureCAPE processing+3Export controls12 piecesLicensing regimeFDPR enforcement+2Trade governance8 piecesAdvisory committeeEXIM reauthorization+1Origin review24 piecesUSMCA reviewAuto rules of origin+1Metals scope review6 piecesSection 232 metalsSection 232 copper+1Tariff relief2 piecesExclusion process
Filtered
Section 301 track stream
Section 301 Has the Tariff Power. The German Drug-Pricing Case Has the Causation Problem.
Section 301 supplies the tariff power IEEPA lacked. The German drug-pricing case is weak instead on statutory fit and the causal chain to U.S. commerce.
Section 232 Is the Pharma Tariff. Drug-Pricing Section 301 Is the Record-Building Track.
Not yet a Section 301 tariff. USTR has opened the drug-pricing record, but the live duty exposure remains Proclamation 11020's Section 232 regime.
